Professional Documents
Culture Documents
Aegis Logistics (AGIS IN) - Q3FY21 Result - PhillipCapital (India)
Aegis Logistics (AGIS IN) - Q3FY21 Result - PhillipCapital (India)
8.5% in 3QFY21 mainly due to revenue mix with decline in low margin sourcing business on SHARE HOLDING PATTERN, %
yoy basis. Employee cost increased by 10.0%yoy to Rs 136mn. Interest cost declined by Dec 20 Sep 20 Jun 20
56.5%yoy to Rs 41mn. PBT declined by 7.3% yoy to Rs 1.2bn, in line with estimates of Rs PROMOTERS : 58.7 58.7 59.7
1.12bn. Adjusted profit declined by 7.4%yoy to Rs 852mn. Aegis reported profit of Rs 712mn FII / NRI : 14.8 14.2 13.2
after adjustment of Rs 140mn for ESOP in 3QFY21 compared to profit of Rs 499mn in FI / MF : 1.9 1.9 2.4
NON PRO : 8.1 8.2 6.9
3QFY20 with ESOP adjustment of Rs 421mn. Standalone revenue declined by 9.2%yoy to Rs
PUBLIC & OTHERS : 16.5 17.0 17.9
1.96bn and EBITDA increased by 1.5% yoy from Rs 674mn in 3QFY20 to Rs 684mn in 3QFY21.
Conference call takeaways KEY FINANCIALS
Volume update: LPG throughput volume in gas segment was down 19.1%yoy to 775,000 Rs mn FY20 FY21E FY22E
Net Sales 71,833 42,277 59,754
tonnes; LPG distribution volume declined by 13.5%yoy to 35,451 tonnes. Management
EBIDTA 5,153 5,246 6,365
expect recovery in high margin retail volumes going ahead. Sourcing volume declined by
Net Profit 3,384 3,004 3,907
15.3%yoy (up 162% qoq) to 374,000 tonnes with pick up in volume by oil PSU EPS, Rs 9.6 8.5 11.0
companies on qoq basis. PER, x 29.6 33.4 25.6
Liquid capacity expansion projects at Mangalore, Kochi and Haldia are expected to EV/EBIDTA, x 19.3 20.0 16.2
complete in 4QFY21 providing growth in FY22. PBV, x 6.1 5.5 4.8
Uran-Chakan LPG pipeline commissioned in June 2020 and rail gantry project for LPG ROE, % 20.5 16.6 18.6
movement at Pipavav completed in December 2020 with additional volume potential of Debt/Equity (%) 35.4 34.2 26.3
0.5mn tonnes each. New LPG project at Kandla with capital expenditure of Rs 3.5bn is
CHANGE IN ESTIMATES
expected to complete in 4QFY21 and management expect c. 1mn tonne volume in FY22.
__Revised Est. __ __% Revision__
New cycle of projects will be taken up over next 2-3 years focusing on improving
Rs mn FY21E FY22E FY21E FY22E
connectivity of existing facilities as well as expansion at new locations. Planning to set Revenue 42,277 59,754 9.1 -7.5
up new LPG terminal in South. EBITDA 5,246 6,365 3.0 2.4
The National Green Tribunal (NGT) Delhi has demanded Rs 1.42bn for alleged air Core PAT 3,004 3,907 4.3 3.2
pollution in Mumbai. The Supreme court has directed a stay on NGT order and company EPS (Rs) 8.5 11.0 4.3 3.2
is hopeful of no material liability arising from same and no provision is made.
Outlook and valuation: At CMP, stock trades at 25.6x our FY22 earnings. We have revised Vikram Suryavanshi, Research Analyst
revenue due to improvement in logistics volume. The company has created a niche in liquid (022 6246 4111) vsuryavanshi@philipcapital.in
and gas logistics and has healthy return ratios with RoCE at 18-25%. Its control on the
complete supply chain helps it to reduce costs and provide reliable services at very
competitive rates. We have revised valuation from 25x FY22 to 23xFY23 EPS to arrive at a
target of Rs 330. (Earlier Rs 265).
Consolidated (Rs mn) 3QFY21 3QFY20 yoy 2QFY21 qoq vs. expect. Comments
growth % %
Revenue 15455 21686 -28.7 6504 137.6 38.0 Sourcing volume down 15.3%yoy, LPG logistics down 19.1%yoy
EBITDA 1319 1518 -13.1 1163 13.4 -3.0 Improvement in liquid segment
EBITDA margins 8.5% 7.0% 22.0 17.9% -52.3 -29.7 Impact of revenue mix
Other income 104 46 125.2 66 56.0 245.3
Depreciation 179 172 4.1 180 -0.5 -3.2
Interest 41 94 -56.5 41 0.5 -48.9
PBT 1203 1298 -7.3 1009 19.2 6.9 In line
Adjusted PAT 852 920 -7.4 710 20.0 13.1
Consolidated
Year End March (Rs mn) 3QFY20 4QFY20 1QFY21 2QFY21 3QFY21
Total Revenue 21686 12417 6364 6504 15455
Cost of material 19908 10332 4727 4868 13674
Purchase of stocks -216 155 153 9 -34
Total material 19693 10487 4880 4877 13641
% of sales 90.8% 84.5% 76.7% 75.0% 88.3%
Employee Cost 124 148 100 117 136
Other expenditure 353 430 289 346 360
Total Expenditure 20169 11065 5269 5341 14136
EBITDA 1518 1352 1095 1163 1319
Margins 7.0% 10.9% 17.2% 17.9% 8.5%
Other income 46 195 50 66 104
Depreciation 172 187 176 180 179
Interest 94 79 47 41 41
PBT 1298 1281 922 1009 1203
Tax 284 394 133 227 280
Effective tax rate 21.9% 30.7% 14.4% 22.5% 23.3%
PAT 1014 887 790 782 923
minority interest 93 125 70 72 71
Adjusted PAT 920 763 720 710 852
Extraordinary -421 -421 -421 -141 -140
Reported PAT 499 341 298 570 712
Equity 340 340 340 340 345
EPS 2.7 2.2 2.1 2.1 2.5
Cash EPS 3.2 2.8 2.6 2.6 3.0
Segmental 21686 12417 6364 6504 15455
Liquid terminal 548 533 554 564 568
Gas Terminal 21139 11883 5810 5939 14887
EBIT 1443 1345 999 1071 1278
Liquid terminal 296 270 308 303 300
Gas Terminal 1147 1074 690 768 977
Volume (tonnes)
Autogas 7328 6866 2944 4756 6159
Packaged cylinders 6551 7580 2553 4499 6042
Industrial- Bulk 26368 31195 7414 23621 23250
LPG Volume (Distribution) 41000 45641 12911 32876 35451
LPG Volume (Logistics)-Gas 958293 728364 700349 722514 775316
Total LPG (tonnes) 999293 774005 713260 755390 810767
Sourcing tonnes 441848 425030 158287 142911 374322
Segmental
Liquid 550 530 554 564 568
EBITDA 356 367 399 395 392
Margins 64.7% 69.2% 72.0% 70.4% 69.0%
Gas
EBITDA 1218 1220 780 850 1080
Margins 5.8% 10.3% 13.4% 14.3% 7.3%
Source: Company, PhillipCapital India Research
Financials
250
150
100
50
0
J-19 M-19 J-19 S-19 D-19 M-20 J-20 S-20 D-20
Rating Methodology
We rate stock on absolute return basis. Our target price for the stocks has an investment horizon of one
year. We have different threshold for large market capitalisation stock and Mid/small market capitalisation
stock. The categorisation of stock based on market capitalisation is as per the SEBI requirement.
which PCIL believe is reliable. PhillipCapital (India) Pvt. Ltd. or any of its group/associate/affiliate companies do not guarantee that such information is accurate
or complete and it should not be relied upon as such. Any opinions expressed reflect judgments at this date and are subject to change without notice.
Important: These disclosures and disclaimers must be read in conjunction with the research report of which it forms part. Receipt and use of the research
report is subject to all aspects of these disclosures and disclaimers. Additional information about the issuers and securities discussed in this research report is
available on request.
Certifications: The research analyst(s) who prepared this research report hereby certifies that the views expressed in this research report accurately reflect the
research analyst’s personal views about all of the subject issuers and/or securities, that the analyst(s) have no known conflict of interest and no part of the
research analyst’s compensation was, is, or will be, directly or indirectly, related to the specific views or recommendations contained in this research report.
Additional Disclosures of Interest:
Unless specifically mentioned in Point No. 9 below:
1. The Research Analyst(s), PCIL, or its associates or relatives of the Research Analyst does not have any financial interest in the company(ies) covered in
this report.
2. The Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively do not hold more than 1% of the securities of the
company (ies)covered in this report as of the end of the month immediately preceding the distribution of the research report.
3. The Research Analyst, his/her associate, his/her relative, and PCIL, do not have any other material conflict of interest at the time of publication of this
research report.
4. The Research Analyst, PCIL, and its associates have not received compensation for investment banking or merchant banking or brokerage services or for
any other products or services from the company(ies) covered in this report, in the past twelve months.
5. The Research Analyst, PCIL or its associates have not managed or co-managed in the previous twelve months, a private or public offering of securities for
the company (ies) covered in this report.
6. PCIL or its associates have not received compensation or other benefits from the company(ies) covered in this report or from any third party, in
connection with the research report.
7. The Research Analyst has not served as an Officer, Director, or employee of the company (ies) covered in the Research report.
8. The Research Analyst and PCIL has not been engaged in market making activity for the company(ies) covered in the Research report.
9. Details of PCIL, Research Analyst and its associates pertaining to the companies covered in the Research report:
Independence: PhillipCapital (India) Pvt. Ltd. has not had an investment banking relationship with, and has not received any compensation for investment
banking services from, the subject issuers in the past twelve (12) months, and PhillipCapital (India) Pvt. Ltd does not anticipate receiving or intend to seek
compensation for investment banking services from the subject issuers in the next three (3) months. PhillipCapital (India) Pvt. Ltd is not a market maker in the
securities mentioned in this research report, although it, or its affiliates/employees, may have positions in, purchase or sell, or be materially interested in any
of the securities covered in the report.
Suitability and Risks: This research report is for informational purposes only and is not tailored to the specific investment objectives, financial situation or
particular requirements of any individual recipient hereof. Certain securities may give rise to substantial risks and may not be suitable for certain investors.
Each investor must make its own determination as to the appropriateness of any securities referred to in this research report based upon the legal, tax and
accounting considerations applicable to such investor and its own investment objectives or strategy, its financial situation and its investing experience. The
value of any security may be positively or adversely affected by changes in foreign exchange or interest rates, as well as by other financial, economic, or
political factors. Past performance is not necessarily indicative of future performance or results.
Sources, Completeness and Accuracy: The material herein is based upon information obtained from sources that PCIPL and the research analyst believe to be
reliable, but neither PCIPL nor the research analyst represents or guarantees that the information contained herein is accurate or complete and it should not
be relied upon as such. Opinions expressed herein are current opinions as of the date appearing on this material, and are subject to change without notice.
Furthermore, PCIPL is under no obligation to update or keep the information current. Without limiting any of the foregoing, in no event shall PCIL, any of its
affiliates/employees or any third party involved in, or related to computing or compiling the information have any liability for any damages of any kind
including but not limited to any direct or consequential loss or damage, however arising, from the use of this document.
Copyright: The copyright in this research report belongs exclusively to PCIPL. All rights are reserved. Any unauthorised use or disclosure is prohibited. No
reprinting or reproduction, in whole or in part, is permitted without the PCIPL’s prior consent, except that a recipient may reprint it for internal circulation only
and only if it is reprinted in its entirety.
Caution: Risk of loss in trading/investment can be substantial and even more than the amount / margin given by you. Investment in securities market are
subject to market risks, you are requested to read all the related documents carefully before investing. You should carefully consider whether
trading/investment is appropriate for you in light of your experience, objectives, financial resources and other relevant circumstances. PhillipCapital and any of
its employees, directors, associates, group entities, or affiliates shall not be liable for losses, if any, incurred by you. You are further cautioned that
trading/investments in financial markets are subject to market risks and are advised to seek independent third party trading/investment advice outside
PhillipCapital/group/associates/affiliates/directors/employees before and during your trading/investment. There is no guarantee/assurance as to returns or
profits or capital protection or appreciation. PhillipCapital and any of its employees, directors, associates, and/or employees, directors, associates of
PhillipCapital’s group entities or affiliates is not inducing you for trading/investing in the financial market(s). Trading/Investment decision is your sole
responsibility. You must also read the Risk Disclosure Document and Do’s and Don’ts before investing.
Kindly note that past performance is not necessarily a guide to future performance.
Additional Disclosures
This research report is for distribution only under such circumstances as may be permitted by applicable law. This research report has no regard to the specific
investment objectives, financial situation or particular needs of any specific recipient, even if sent only to a single recipient. This research report is not
guaranteed to be a complete statement or summary of any securities, markets, reports or developments referred to in this research report. Neither
PHILLIPCAP nor any of its directors, officers, employees or agents shall have any liability, however arising, for any error, inaccuracy or incompleteness of fact or
opinion in this research report or lack of care in this research report’s preparation or publication, or any losses or damages which may arise from the use of
this research report.
PHILLIPCAP may rely on information barriers, such as “Chinese Walls” to control the flow of information within the areas, units, divisions, groups, or affiliates
of PHILLIPCAP.
Investing in any non-U.S. securities or related financial instruments (including ADRs) discussed in this research report may present certain risks. The securities
of non-U.S. issuers may not be registered with, or be subject to the regulations of, the U.S. Securities and Exchange Commission. Information on such non-U.S.
securities or related financial instruments may be limited. Foreign companies may not be subject to audit and reporting standards and regulatory
requirements comparable to those in effect within the United States.
The value of any investment or income from any securities or related financial instruments discussed in this research report denominated in a currency other
than U.S. dollars is subject to exchange rate fluctuations that may have a positive or adverse effect on the value of or income from such securities or related
financial instruments.
Past performance is not necessarily a guide to future performance and no representation or warranty, express or implied, is made by PHILLIPCAP with respect
to future performance. Income from investments may fluctuate. The price or value of the investments to which this research report relates, either directly or
indirectly, may fall or rise against the interest of investors. Any recommendation or opinion contained in this research report may become outdated as a
consequence of changes in the environment in which the issuer of the securities under analysis operates, in addition to changes in the estimates and forecasts,
assumptions and valuation methodology used herein.
No part of the content of this research report may be copied, forwarded or duplicated in any form or by any means without the prior written consent of
PHILLIPCAP and PHILLIPCAP accepts no liability whatsoever for the actions of third parties in this respect.
SURYAVANS
2.5.4.20=05b3477dbcbe37348e8f28e3d6a0c12da3
43db31e5ec7bfb8f3420bbd40b5b12,
postalCode=400013, st=Maharashtra,
serialNumber=eb1164cde1b22a71dddeeaf58164a
HI
72cdc84d4d9f522eff6df41efb8603abf1a,
cn=VIKRAM V SURYAVANSHI
Date: 2021.02.01 09:14:20 +05'30'